Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$35.48 USD
+0.65 (1.87%)
Updated Oct 14, 2024 03:59 PM ET
After-Market: $35.46 -0.02 (-0.06%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Price, Consensus and EPS Surprise
HRMY 35.48 +0.65(1.87%)
Will HRMY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for HRMY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HRMY
Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?
HRMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know
HRMY vs. REGN: Which Stock Should Value Investors Buy Now?
HRMY or REGN: Which Is the Better Value Stock Right Now?
Other News for HRMY
IYH: Healthcare Dashboard For October
Nike upgraded, PayPal downgraded: Wall Street's top analyst calls
Harmony Biosciences resumed with an Outperform at Raymond James
Harmony Biosciences price target raised by $10 at Mizuho, here's why
Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth ...